This topic contains a solution. Click here to go to the answer

Author Question: A patient with renal failure is undergoing chronic hemodialysis. The patient's hemoglobin is 10.6 ... (Read 50 times)

rlane42

  • Hero Member
  • *****
  • Posts: 594
A patient with renal failure is undergoing chronic hemodialysis. The patient's hemoglobin is 10.6 gm/dL. The provider orders sodiumferric gluconate complex (SFGC Ferrlecit). What will the nurse expect to do?
 
  a. Administer the drug intravenously with erythropoietin.
  b. Give a test dose before each administration of the drug.
  c. Have epinephrine on hand to treat anaphylaxis if needed.
  d. Infuse the drug rapidly to achieve maximum effects quickly.

Question 2

A nurse is caring for a patient with hemophilia A who has been admitted for bleeding into the knee joint.
 
  The prescriber has ordered intravenous factor VIIa (NovoSeven RT). A nursing student wants to know why this patient is not receiving factor VIII. Which statement by the nurse is correct?
  a. Factor VIIa is stronger than factor VIII and will work faster.
  b. Factor VIII is used for prophylaxis, and factor VIIa is used for acute episodes.
  c. Factor VIIa is used when patients develop antibodies against factor VIII.
  d. Factor VIIa provides immune tolerance therapy so that factor VIII will be more effective.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amanda_14

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: A
SFGC is given parenterally for iron deficiency anemia in patients undergoing chronic hemodialysis. It is always used in conjunction with erythropoietin to stimulate production of red blood cells (RBCs). A test dose is given only with the initial dose and is not necessary with subsequent doses. Anaphylaxis is not a common side effect. The drug should be infused slowly.

Answer to Question 2

ANS: C
When patients develop antibodies against factor VIII, activated factor VII is used, because it has the same actions as factor VIII. Factor VIIa is not stronger than factor VIII. It is not used for prophylaxis only. Immune tolerance therapy describes the use of repeated administration of factor replacement products to eliminate inhibitor production.





 

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Dogs have been used in studies to detect various cancers in human subjects. They have been trained to sniff breath samples from humans that were collected by having them breathe into special tubes. These people included 55 lung cancer patients, 31 breast cancer patients, and 83 cancer-free patients. The dogs detected 54 of the 55 lung cancer patients as having cancer, detected 28 of the 31 breast cancer patients, and gave only three false-positive results (detecting cancer in people who didn't have it).

For a complete list of videos, visit our video library